Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants
Journal of Innate Immunity · 29.05.2026 · 18 (1) · 315-333
DOI: 10.1159/000552360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 29.05.2026. Verfasst von Laura A Novotny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Receptors, Interferon, Hepatocytes, Hepatitis B virus. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Introduction
Lambda interferons signal through the interferon lambda receptor 1 (IFNLR1) and IL10RB heterodimer to induce interferon stimulated genes (ISGs). We previously showed that proteins derived from distinct IFNLR1 splice isoforms uniquely influence gene expression and hepatitis B virus replication in stem cell-derived hepatocytes (iHeps). Here, we evaluated signal transduction mechanisms of full-length IFNLR1 (variant 1) and a truncated variant missing part of the cytoplasmic JAK1-interacting domain (variant 2).
Methods
We evaluated HEK293T cells, wild-type (WT), and IFNLR1 knockout (KO) iHeps with doxycycline-inducible expression of FLAG-tagged IFNLR1 variants using the Duolink proximity ligation assay, ImageStream flow cytometry, Western blotting, susceptibility to JAK1 and TYK2 inhibitors, and gene expression profiling.
Results
Each variant colocalized with IL10RB after IFNL3 treatment, but variant 1 was more rapidly and extensively internalized. In WT iHeps, overexpression of variant 1 or variant 2 enabled higher IFNL-induced JAK1, TYK2, STAT1, and STAT2 phosphorylation, yet variant 2 supported less robust ISG induction. In KO iHeps, variant 2 supported less JAK1 and TYK2 phosphorylation and ISG induction than variant 1, yet supported comparable STAT1 and STAT2 phosphorylation. In iHeps expressing variant 1, WT iHeps were more resistant than KO iHeps to TYK2 inhibition of antiviral ISG induction, yet were more susceptible to TYK2 inhibition of proinflammatory ISG induction, suggesting endogenous noncanonical variants influence TYK2-signaling dependence.
Conclusion
IFNLR1 variants promote differential utilization of signaling mediators to influence IFNL-induced gene expression patterns, indicating a putative role in pathway regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA, meissner@musc.edu.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA, meissner@musc.edu.
Förderung
- NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Novotny, L. A., Martinez-Morant, C., Duncan, S. A., Traktman, P., Gooz, M., & Meissner, E. G. (2026). Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants. Journal of Innate Immunity, 18(1), 315-333. https://doi.org/10.1159/000552360
Vancouver
Novotny LA, Martinez-Morant C, Duncan SA, Traktman P, Gooz M, Meissner EG. Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants. Journal of Innate Immunity. 2026;18(1):315-333. doi:10.1159/000552360
BibTeX
@article{Novotny2026,
author = {Novotny, Laura A and Martinez-Morant, Carla and Duncan, Stephen A and Traktman, Paula and Gooz, Monika and Meissner, Eric G},
title = {Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants},
journal = {Journal of Innate Immunity},
year = {2026},
volume = {18},
number = {1},
pages = {315--333},
doi = {10.1159/000552360}
}
EUVIMED